The recent approvals of Leqembi (lecanemab) and Kisunla (donanemab) have refreshed the landscape of Alzheimer’s disease treatments. For the first time, patients have the option to take a drug that could slow the progression of the fatal disease and afford them more valuable time and cognitive…
Injectable Alzheimer’s Drugs Could Save Patients Trips to the Hospital …C0NTINUE READING >>>>